Literature DB >> 12352463

The role of caveolin-1 in androgen insensitive prostate cancer.

Vladimir Mouraviev1, Likun Li, Salahaldin A Tahir, Guang Yang, Terry M Timme, Alexei Goltsov, Chengzhen Ren, Takefumi Satoh, Thomas M Wheeler, Michael M Ittmann, Brian J Miles, Robert J Amato, Dov Kadmon, Timothy C Thompson.   

Abstract

PURPOSE: We summarize the literature regarding androgen insensitive prostate cancer and caveolin-1. Caveolin-1 is a major structural component of caveolae, membrane micro-domains known to have important roles in signal transduction and lipid transport.
MATERIALS AND METHODS: A review of the literature relevant to androgen insensitive caveolin-1 and prostate cancer included the first published report in 1998 through those published in March 2002.
RESULTS: Caveolin-1 expression is increased in primary and metastatic human prostate cancer with highest levels observed after androgen ablation therapy. Recent studies have documented that caveolin-1 is secreted by prostate cancer cells and can be detected in the serum of men with prostate cancer.
CONCLUSIONS: The results presented in this review establish that caveolin-1 is an autocrine/paracrine factor associated with androgen insensitive prostate cancer. They show the potential for caveolin-1 as a biomarker therapeutic target for this important malignancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352463     DOI: 10.1097/01.ju.0000030164.80605.b9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Genetic variations of CAV1 gene contribute to HCC risk: a case-control study.

Authors:  Xixue Zhao; Guozheng Pan; Qingzhong Yuan; Dongpo Mu; Jun Zhang; Tao Cui; Jian Zhang; Linghai Zhang
Journal:  Tumour Biol       Date:  2014-08-13

Review 2.  Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology.

Authors:  Aritro Sen; Hen Prizant; Stephen R Hammes
Journal:  Steroids       Date:  2011-02-25       Impact factor: 2.668

3.  Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics.

Authors:  Shu-Ru Kuo; Salahaldin A Tahir; Sanghee Park; Timothy C Thompson; Scott Coffield; Arthur E Frankel; Jen-Sing Liu
Journal:  Hybridoma (Larchmt)       Date:  2012-04

4.  Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.

Authors:  Terence M Williams; Federica Sotgia; Hyangkyu Lee; Ghada Hassan; Dolores Di Vizio; Gloria Bonuccelli; Franco Capozza; Isabelle Mercier; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

5.  Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.

Authors:  Likun Li; Chengzhen Ren; Guang Yang; Alexei A Goltsov; Ken-ichi Tabata; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

6.  Long-chain saturated fatty acids induce annexin II translocation to detergent-resistant membranes.

Authors:  Hong Zhao; Robert W Hardy
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

7.  Role of caveolin-1 in the regulation of lipoprotein metabolism.

Authors:  Philippe G Frank; Stephanos Pavlides; Michelle W-C Cheung; Kristin Daumer; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2008-05-28       Impact factor: 4.249

Review 8.  Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.

Authors:  T Karantanos; P G Corn; T C Thompson
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

9.  Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

Authors:  Likun Li; Cheng Hui Ren; Salahaldin A Tahir; Chengzhen Ren; Timothy C Thompson
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Caveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cells.

Authors:  Maria Katsogiannou; Charbel El Boustany; Florian Gackiere; Philippe Delcourt; Anne Athias; Pascal Mariot; Etienne Dewailly; Nathalie Jouy; Christophe Lamaze; Gabriel Bidaux; Brigitte Mauroy; Natalia Prevarskaya; Christian Slomianny
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.